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in the urine collected from the obstructed pelvis and the MAG3MCP-1 and EGF renal expression and urine excretion in hu-
clearance of the obstructed kidney (r 5 20.76). The presenceman congenital obstructive nephropathy.
of recurrent UTI was associated with a significantly higherBackground. Obstructive nephropathy is characterized at
MCP-1 excretion and a slight reduction in EGF urine concen-the histologic level by tubular atrophy and interstitial monocyte
tration. The surgical correction of UPJO was followed by aninfiltration. The molecular mechanisms underlying these histo-
logic changes are still poorly defined. Epidermal growth factor improvement of renal function together with a significant re-
(EGF) produced by tubular cells seems to play a pivotal role duction in MCP-1 excretion and a marked increase in EGF
in the modulation of tubular cell growth, while monocyte che- urine concentrations. Interestingly, EGF urine concentration
motactic peptide-1 (MCP-1) is a powerful and specific chemo- measured before surgery was significantly correlated with the
tactic and activating factor for monocytes. difference between the MAG3 clearance of the obstructed
Methods. Twenty-four patients with congenital ureteropel- kidney before and after surgery.
vic junction obstruction [UPJO; 10 with recurrent urinary tract Conclusions. MCP-1 and EGF seem to be involved in the
infection (UTI) and 10 with no UTI] and 15 healthy children pathogenesis of tubulointerstitial damage in congenital ob-
were studied. Diagnosis was made by renal ultrasound, intrave- structive nephropathy, and their urine excretion may represent
nous pielography, and MAG3 scan. Urinary samples were col- a powerful prognostic marker in this form of renal disease.
lected before and after surgery. In 10 patients, urine was also
collected directly from the affected pelvis at the time of surgery.
Urinary EGF and MCP-1 levels were measured by enzyme-
Chronic obstructive nephropathy is characterized atlinked immunosorbent assay. MCP-1 and EGF gene expression
were evaluated by in situ hybridization in 15 biopsies from the histopathological level by tubular atrophy and inter-
congenital UPJO and in 10 normal kidneys. stitial fibrosis [1]. Although the acute hemodynamic and
Results. In normal kidneys, there was a high expression functional abnormalities associated with obstructive uro-of EGF mRNA, whereas MCP-1 mRNA was undetectable.
pathy have been clarified, the cellular and molecularMCP-1 gene expression was strikingly increased at the tubulo-
interstitial level in UPJO biopsies compared with controls and mechanisms leading to the chronic histologic lesions are
was directly correlated with the extent of monocyte infiltration. still largely unknown [2–4].
In addition, UPJO kidney sections showed a marked reduction In the last few years, the interest of different investiga-
in EGF gene expression that was directly correlated with the
tors has been focused on the presence of infiltratingdegree of tubular damage. EGF urine concentration was sig-
monocytes in the interstitial space of the obstructed kid-nificantly reduced in UPJO when compared with control and
directly correlated with its renal gene expression. On the other ney [5–7]. These bone marrow-derived cells may repre-
hand, the MCP-1 urine concentration was strikingly increased sent a potential source of cytokines and growth factors
in UPJO patients. It is noteworthy that a significant and inverse promoting the activation of resident cells and therefore
correlation was observed between the MCP-1 concentration
playing a pivotal role in the pathogenesis of tubulointer-
stitial damage [8–10]. Indeed, Harris, Schreiner, and
1 Dr. Grandaliano and Dr. Gesualdo contributed equally to the present Klahr have clearly demonstrated that infiltrating mono-
work. cytes contribute to the acute decline in renal function
after the onset of experimental hydronephrosis [11].Key words: chemokines, growth factors, congenital ureteropelvic junc-
tion obstruction, MAG3, monocyte. Although the presence of monocytes within the inter-
stitial space in experimental hydronephrosis and their
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Table 1. Main clinical features of the uretopelvic junctionlocal release of chemokines could play a key pathogenic
obstruction (UPJO) patients enrolled in the study
role in this scenario [12]. Diamond et al showed an in-
Age MAG3 clearancecreased monocyte chemotactic peptide-1 (MCP-1) pro-
Patients months Gender %tein expression after unilateral obstruction in rats, in
C.D. 5 M 34temporal concordance with the increase in interstitial
C.M. 72 M 55
macrophage number [6]. MCP-1 is a powerful and spe- C.G. 96 M 53
C.F. 6 M NAcific chemotactic and activating factor for monocytes
C.C. 156 M 64[13]. An increased expression of this chemokine has been
D.S. 11 M 51
demonstrated by our group in different acute and chronic D.A. 2 F NA
D.G. 13 M 19human tubulointerstitial diseases [14]. Moreover, the
D.M. 11 M 31MCP-1 renal expression and urine excretion were strictly
G.M. 6 M 49
correlated with the tubular damage and the extent of L.F. 12 M 71
L.A. 2 M 58monocyte infiltration, supporting a role for this chemo-
L.E. 13 F 49kine in the pathogenesis of tubulointerstitial injury [14].
L.R. 32 M NA
On the other hand, epidermal growth factor (EGF), L.V. 18 M 44
M.C. 1 F NAproduced by the ascending portion of the Henle’s loop
M.F. 5 M 55and the distal convoluted tubule, is a peptide growth
M.M. 48 F 74
factor that modulates epithelial cell growth and metabo- P.L. 24 M 66
P.D. 15 M 74lism [15, 16]. It has been suggested as a mediator of
S.L. 2 M NAnormal tubulogenesis and tubular regeneration after in-
S.A. 9 M 59
jury. A reduction in renal EGF expression and/or urinary V.M. 24 M 56
Z.S. 2 M 12excretion has been reported during acute and chronic
tubular injury, including an experimental model of hy- NA is not available.
dronephrosis [17–19]. Moreover, the administration of
EGF in animal models of acute ischemic tubular necrosis
and hydronephrosis has been shown to accelerate the
excreted) was 52.6% (range 19 to 75%). None of thetubular regeneration and to attenuate tubular damage
patients had clinical signs or laboratory markers of activeand apoptosis [20–22]. However, no information is avail-
infection, while 10 of them had a positive history forable on the tubular expression and urine excretion of
recurrent urinary tract infection (UTI), and 10 had nothis growth factor in human chronic obstructive ne-
history of UTI. Urinary samples were collected beforephropathy.
and between two and four months after surgery. In 10In the present study, we investigated EGF and MCP-1
patients with UPJO, urine was collected directly fromrenal gene expression and EGF and MCP-1 urine ex-
the obstructed pelvis with a 22-gauge needle cannula.cretion in human congenital obstructive nephropathy
All of the patients underwent pieloplasty, and in 16 pa-caused by ureteropelvic junction obstruction (UPJO),
tients, a kidney biopsy was performed during surgery.and their correlation with the main histologic and clinical
Ten apparently normal portions of kidneys removed forfindings.
renal carcinoma were used as control. Ten patients were
followed after surgery for a mean period of 16.7 months
METHODS (range 11 to 24), after which they repeated the MAG3
Patients scan.
Twenty-four children affected by congenital UPJO
In situ hybridizationand 15 healthy children were included in the study after
Renal tissue was immediately included in OCT (Tis-their parents gave informed consent. The main clinical
sue-Tek, Elkhart, IN, USA, USA), snap-frozen in liquidfeatures of the patients enrolled in the study are summa-
nitrogen, and stored in the same liquid until used. Frozenrized in Table 1. Diagnosis of UPJO was made by renal
sections (6 mm thick) were collected onto polylysine-ultrasound, cistography, intravenous pielography, and
coated slides, dried briefly on a hot plate at 808C, andMAG3 scan. The last two tests were performed with
fixed in 4% paraformaldehyde for 20 minutes. After twodiuretic stimulation (furosemide 0.5 mg/kg intravenous
washes in phosphate-buffered saline (PBS), dehydrationbolus) to discriminate obstructive from nonobstructive
in graded ethanol, and short air drying, sections wereUPJO. Five patients had a prenatal diagnosis of hydrone-
immediately used for in situ hybridization.phrosis. Vescico-ureteral reflux was ruled out in all of
Human MCP-1 [14] and EGF cDNA fragments [18]the cases. All cases had normal blood urea nitrogen
were subcloned into pGEM3Zf. After linearization ofand creatinine levels. The mean total MAG3 clearance
(expressed as the percentage of the radioactive tracer the plasmid with either BamH I or Xba I restriction
Grandaliano et al: Markers of obstructive nephropathy184
endonucleases, T7 or SP6 RNA-polymerases (Boeh- sin (immunohistochemistry), and silver grains (in situ
hybridization) were quantitated by a computer-basedringer Mannheim, Mannheim, Germany), respectively,
were employed to obtain run off transcripts of either the morphometric analysis system in 6 to 10 randomly se-
lected interstitial areas. The video image was generatedantisense (complementary to mRNA) or sense (negative
control) strands. Transcription and labeling of RNA by a video camera (Hamamatsu, Milan, Italy) connected
through a frame grabber (Hamamatsu) to a Power PCprobes were performed as described [15]. Briefly, 80 mCi
of [35S]uridine-59-(a-thio)-triphosphate (specific activity, computer (Macintosh, Cupertino, CA, USA). Single im-
ages were digitized for image analysis at 256 gray levels.1250 Ci/mmol; Amersham, Little Chalfont, UK) were
added to a 10 mL reaction mixture (0.5 mmol/L each of Imported data were analyzed quantitatively by an Opti-
lab Pro 2.6.1 Software (Graftek, Villanterio, PV, Italy),adenosine-, cytosine-, and guanosine-59-triphosphate/
1 mmol/L dithiothreitol/10 U human placental RNase which operated a color-based pitch densitometry. The
structures of interest were interactively discriminated byinhibitor/6 mmol/L MgCl2/10 mmol/L Tris-HCl, pH 7.5/
2 mmol/L spermidine/10 mmol/L NaCl), including 1 mg the operators using the cursor and then automatically
measured for total area. An optical threshold and filterof linearized plasmid and 16 U of either SP6 or T7 RNA
polymerase. The reaction was allowed to proceed for 60 combination were set to select only the nuclei of CD68-
positive interstitial cells, the interstitial fibrosis (evalu-minutes at 388C. The plasmid DNA was removed by
digestion with 25 mg/mL RNase-free DNase I in a mix- ated by Masson’s Trichromic staining), the new Fuchsin
deposits, or the silver grains.ture containing 2.5 mg/mL of yeast tRNA and 10 U of
RNase inhibitor for 10 minutes at 378C. Free ribonucleo- CD68-positive cells nuclei were then counted and ex-
pressed in the number of cells per area, while areas oftides were removed by phenol-chloroform extraction fol-
lowed by ethanol precipitation. RNA probes were then green staining (interstitial fibrosis as identified by Mas-
son’s trichromic) were extracted, quantitated, and ex-diluted in hybridization buffer, stored at 2808C, and
used within four weeks. The specific activity usually ob- pressed as a percentage of the total interstitial area.
MCP-1 and EGF expression (silver grains) were quanti-tained was 1.2 to 1.4 3 109 cpm/mg of 35S-labeled RNA
probe. tated by computer-assisted densitometric procedure and
were expressed as arbitrary units (A.U.)/pixel. Finally,Prehybridization, hybridization, removal of non spe-
cifically bound probe by RNase A digestion, and further tubular damage was evaluated semiquantitatively in a
blind fashion by three independent observers using awashing procedures were performed for both sense and
antisense probes as described previously [14, 15, 18]. scale ranging from 0 to 4, on the basis of the percentage
of atrophic and/or dilated tubular sections. Using theAutoradiography was performed by dipping the dehy-
drated slides into Ilford G5 nuclear emulsion (Ilford, Statview II Software (Brain Power Inc., Calabasas, CA,
USA), the individual data for each variable were tabu-Mobberley Cheshire, UK). The exposed slides were de-
veloped using Kodak D19 developer (Kodak, Hemel lated, and Pearson’s correlation coefficients were calcu-
lated.Hampstead, UK), counterstained in hematoxylin and eo-
sin, and finally mounted.
Enzyme-linked immunosorbent assay (ELISA)
Immunohistochemistry Urine samples were collected from the patients in-
cluded in the study before surgery. In 14 congenitalThe immunohistochemical detection of infiltrating
monocytes was performed on frozen 4 mm thick kidney UPJO patients, a second urine sample was obtained be-
tween the second and fourth months after surgery. Urinesections and was fixed in 4% paraformaldehyde, using
a chromatographically purified mouse anti-CD68 mono- samples were also obtained from 15 healthy controls
strictly matched for age. Urine samples were centrifugedclonal antibody, specific for human monocytes (Clone
EBM11; Dako, Milan, Italy) as previously described [14]. at 600 3 g for five minutes and frozen at 2208C until
tested. Quantitative determination of MCP-1 and EGFImmobilized mouse antibodies were detected by the im-
munoalkaline phosphatase (APAAP) method with af- urine concentration were performed using a human
MCP-1 and EGF ELISA kit (Quantikine; R&D, Abing-finity-purified rabbit antimouse IgG antibodies (Dako)
and APAAP complex (1:50 dilution; Dako) following don, UK, and Biotrak, Amersham, UK, respectively), a
multiple sandwich solid-phase enzyme immunoassay thata two-step technique as previously described. Alkaline
phosphatase was developed with New Fuchsin (Sigma, used monoclonal antibodies raised against human
MCP-1 and EGF. The sensitivity of the ELISA wasMilan, Italy). Negative controls were performed by omit-
ting the primary or secondary antibodies and employing 5 pg/mL for MCP-1 and 8 pg/mL for EGF. The enzymatic
reaction was detected in an automatic microplate pho-nonimmune mouse antiserum as first layer.
The histologic lesions and the optical density of the tometer (Titertek; Flow Labs, Helsinki, Finland). The
MCP-1 and EGF concentration of the unknown samplessignals generated by the periodic acid-Schiff and Mas-
son’s Trichromic staining (light microscopy), New Fuch- was determined by interpolation into a standard curve
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Fig. 1. In situ hybridization for epidermal growth factor (EGF). Bright (A and C) and dark (B and D) field microphotographs of normal appearing
kidney (A and B, 3400) and of biopsy specimens from patients with congenital ureteropelvic junction obstruction (UPJO; C and D, 3400) are
shown. In normal kidney, a very high EGF mRNA expression can be observed, whereas in the UPJO sections, there is a striking decrease of the
specific signal.
developed with known amounts of recombinant human genesis of tubular damage [18, 24], the renal EGF gene
expression was evaluated by in situ hybridization in 16MCP-1 and EGF. Urine MCP-1 and EGF protein levels
biopsy sections of congenital UPJO. Control kidneyswere normalized to urine creatinine excretion and were
showed a very high basal expression of this growth factorexpressed as pg or ng/mg urine creatinine, respectively.
(Fig. 1 A, B). The specific hybridization signal was mainly
Statistical analysis located within the loop of Henle and the distal tubules,
as we have previously demonstrated [15]. In UPJO, theData were expressed as mean 6 SEM. Quantitative
intensity of the signal was strikingly reduced when com-data were compared among the groups by analysis of
pared with control kidneys (Fig. 1 C, D) and was inverselyvariance and paired t-test, as appropriate. The correla-
correlated with the degree of tubular damage (r 5 0.65,tion coefficients are Pearson’s r values. Differences were
P , 0.01).considered to be significant when P , 0.05.
Recently, several studies reported that interstitial in-
flammation is a constant feature in experimental models
RESULTS of chronic obstructive uropathy [6, 7, 11]. The inflamma-
Tubular damage, mainly characterized by tubular dila- tory infiltrate has been characterized as constituted
tion and tubular cell atrophy, is one of the histologic mainly by monocytes and T lymphocytes [6, 7]. Thus,
hallmarks of chronic obstructive nephropathy [1, 23]. the presence of interstitial monocytes in the biopsy cores
Since in other acute and chronic tubulointerstitial dis- of congenital UPJO was investigated by immunohisto-
eases the modulation of local EGF production and re- chemistry, using an anti-CD68 antibody, which preferen-
tially recognizes the monocytes coming from the circula-lease has been suggested to be directly involved in patho-
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Fig. 2. Immunohistochemistry for CD68 in human renal biopsy specimens from normal (A, 3200) and obstructed kidneys (B–D, 3400). Sections
demonstrate a diffuse interstitial infiltrate primarily represented by CD68-positive cells.
tion rather than the tissue macrophages. In UPJO, an (Fig. 3 C–F), and was directly correlated with the extent
of monocyte infiltration (r 5 0.90, P , 0.001). To confirminterstitial mononuclear cell infiltrate was present in each
biopsy and was mostly represented by CD68-positive the relevance of MCP-1 expression in the pathogenesis
of interstitial monocyte influx, sequential sections werecells (Fig. 2). The glomeruli were free of specific staining
in all of the sections studied. The extent of monocyte stained for CD68 and were hybridized for MCP-1 (Figs.
2D and 3 E–F). As shown, the tubules expressing MCP-1infiltration was strictly correlated with the degree of tu-
bulointerstitial damage, as expressed by tubular atrophy are surrounded by a CD68-positive cell infiltrate,
strongly supporting a role for this chemokine in intersti-and interstitial fibrosis.
Diamond et al demonstrated an increase in MCP-1 tial monocyte recruitment.
The reduced renal expression of EGF paralleled withprotein expression in an experimental model of hydrone-
phrosis and suggested this chemokine as the main media- its urine excretion evaluated before the surgical correc-
tion of congenital UPJO. The EGF urine concentration,tor of monocyte influx into the interstitium [6]. Since no
similar observation has been reported in human obstruc- indeed, was significantly lower in UPJO then in healthy
subjects (Fig. 4A), although no significant correlationtive nephropathy, the MCP-1 gene expression was evalu-
ated by in situ hybridization in the biopsy sections of could be observed between the renal functional parame-
ters obtained by MAG3 scan and the EGF concentrationcongenital UPJO patients. The specific hybridization sig-
nal for this chemokine was barely detectable in the nor- measured either in urine spot or in the urine collected
directly from the obstructed pelvis.mal kidneys (Fig. 3 A, B). On the other hand, MCP-1
mRNA was markedly increased in the obstructed kid- Also, MCP-1 urine excretion mirrored the renal gene
expression. A striking increase of this chemokine in theneys (Fig. 3 C, D). The specific message was mainly
localized within the tubules, the infiltrating mononuclear urine was observed in the samples collected from the
patients prior to surgery (Fig. 4B). MCP-1 urine concen-interstitial cells and the endothelial cells of small vessels
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Fig. 3. In situ hybridization for monocyte chemotactic peptide-1 (MCP-1). A bright (A, C, and E) and dark (B, D, and F ) field microphotograph
of normal appearing kidney (A and B, 3200) and of biopsy specimens from patients with congenital UPJO (C–F, 3200) is shown. Normal kidney
does not express MCP-1 mRNA, whereas in the UPJO sections, there is a striking increase of the specific signal, mainly localized at the
tubulointerstitial level.
tration was significantly and directly correlated with the Ten of the 24 congenital UPJO patients enrolled in
the study presented with a history of recurrent UTI,mean time of transit of 99Tc-MAG3 through the cortex
of the obstructed kidney (Fig. 5A). Interestingly, the while 10 of them had no history of UTI. The recurrent
UTI group was characterized by a MAG3 clearance sig-MCP-1 concentration in the urine collected directly from
the obstructed pelvis was inversely correlated with the nificantly lower than the group without history of UTI
(UTI 40.0 6 8.7%; without UTI 59.3 6 3.6%, P 5 0.03).MAG3 clearance of the diseased kidney (Fig. 5B).
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Fig. 4. EGF (A) and MCP-1 (B) urine excretion in healthy subjects
Fig. 5. Correlation between MCP-1 excretion and functional parame-and in patients affected by congenital UPJO. MCP-1 and EGF urine
ters obtained by MAG3 scan. MCP-1 urine concentration was signifi-concentrations were measured as described in the Methods section and
cantly and directly correlated with the mean time of transit (MTT) ofwere normalized to urine creatinine excretion. Data are represented as
the radioactive tracer through the cortex of the obstructed kidney (A;mean 6 SEM. *P , 0.01 vs. control.
r 5 0.565, P , 0.03). On the other hand, the MCP-1 concentration in
the urine collected directly from the obstructed pelvis (pMCP-1) was
inversely correlated with the MAG3 clearance of the diseased kidney
(B; r 5 0.769, P , 0.01).
EGF urine excretion, although slightly reduced, was not
significantly lower in the recurrent UTI group when com-
pared with the patients without a history of UTI (Fig. ance of the obstructed kidney (Fig. 7) and a statistically
6A). MCP-1 urine concentration was significantly higher significant increase in EGF urine excretion that returned
in the group of patients with a history of recurrent UTI to normal levels within four months after surgery (Fig.
than in the group with no history of UTI (Fig. 6B). 8A). MCP-1 excretion was markedly reduced after sur-
However, in the latter group, MCP-1 urine concentration gery (Fig. 8B), reaching normal levels four months after
was still higher than in the normal subjects (Fig. 6B). To the surgical correction of the obstruction. Interestingly,
exclude the possibility of an increased production of EGF urine excretion measured before the surgical cor-
this chemokine by epithelial cells along the urinary tract rection of UPJO was directly and significantly correlated
rather than by tubulointerstitial cells, renal MCP-1 ex- with the difference between MAG3 clearance of the
pression was quantitated in the two groups of patients. obstructed kidney before and after surgery (r 5 0.90,
MCP-1 tubulointerstitial expression in the patients with P , 0.001).
recurrent UTI was significantly higher than in patients
without infections (no UTI 60 6 9, UTI 160 6 19 A.U./
DISCUSSIONpixel, P , 0.001).
Interestingly, the surgical correction of congenital Obstructive uropathy accounts for 2% of the end-stage
renal disease (ESRD) patients in renal replacement ther-UPJO was followed by an improvement in MAG3 clear-
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Fig. 7. MAG3 clearance in obstructed ( ) and nonobstructed (j)
kidneys before and after surgical correction of congenital UPJO.
MAG3 clearance is expressed as the percentage of radioactive tracer
excreted by each kidney. *P , 0.01 vs. obstructed kidney after surgery
and nonobstructed kidney before and after surgery.
injury in the animals is always synchronized, whereas in
human studies the investigators have to deal with a cross-
section picture in which the lesions are often represented
at different stages in the different subjects studied. Nev-
ertheless, confirming in humans the molecular informa-
tion collected from the disease in experimental models
is a necessary and unavoidable step. To our knowledge,
the present study is the first attempt to elucidate the
Fig. 6. EGF (A) and MCP-1 (B) urine excretion in congenital UPJO molecular mechanisms involved in the development of
patients with and without a history of recurrent urinary tract infection tubular damage and interstitial inflammation in human(UTI). MCP-1 and EGF urine concentrations were measured as de-
obstructive uropathy caused by congenital UPJO.scribed in the Methods section and were normalized to urine creatinine
excretion. Data are represented as mean 6 SEM. *P , 0.01 vs. control; The modulation of tubular epithelial cell trophism has
**P , 0.01 vs. no UTI. been extensively studied in the experimental model of
obstructive uropathy. Gobe and Axelsen were the first
to observe the apoptosis of tubular cells in a rat model
apy in the U.S. Renal Data System, and this cause of of hydronephrosis [27]. Successively, Truong et al re-
chronic renal failure is particularly relevant among the ported a rapid increase in tubular cell apoptosis associ-
pediatric population [25, 26]. Although the etiology and ated with a decrease in kidney dry weight and mean
the acute hemodynamic and functional abnormalities are tubular diameter, suggesting apoptosis as a central event
well characterized in most of the cases, the pathogenesis in the pathogenesis of tubular atrophy and renal weight
loss [28]. EGF may play a key role in this scenario. Thisof the chronic renal damage secondary to the urinary
tract obstruction is still largely unknown [2–4]. growth factor has been suggested as a powerful trophic
factor for tubular epithelial cells [16, 29]. Indeed, it di-Several studies investigated the cellular and molecular
mechanisms underlying the development of renal lesions rects renal cell proliferation during fetal life and inhibits
in vivo and in vitro tubular cell apoptosis [29–32]. More-induced by chronic urinary tract obstruction in an experi-
mental model created by unilateral ureter ligation [3]. over, several studies have demonstrated the pathogenic
involvement of EGF in acute and chronic forms of renalHowever, the human disease is more complex than its
experimental counterpart. Indeed, while the influence of damage [17–19]. Finally, the administration of recombi-
nant EGF has been shown to reduce tubular necrosissingle or recurrent UTI is excluded in the animal model
of hydronephrosis, this complication is often present in and/or apoptosis and to improve tubular cell regenera-
tion in different models of tubular injury, including ex-human obstructive uropathy. Moreover, as for other ex-
perimental models of renal disease, development of the perimental hydronephrosis [20–22, 33].
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clearance of the obstructed kidney after surgery. Inter-
estingly, the local decrease in EGF production seems to
be primarily induced by the obstruction per se. Indeed,
the surgical correction of the congenital UPJO resulted
in a marked increase in EGF excretion that returned to
normal levels within four months from surgery. How-
ever, EGF excretion may be also influenced, at least in
part, by the presence of recurrent infections, as suggested
by the observation of a lower, although not statistically
different, EGF urine concentration in the patients with
a history of recurrent UTI.
A histologic feature of obstructive uropathy that is
receiving more and more attention in the last few years is
the interstitial inflammatory infiltrate [7]. In our patient
population, this infiltrate is mainly constituted by mono-
cytes, confirming the observation of Schreiner et al in
experimental hydronephrosis [7]. Monocytes, once with-
in the interstitial space, may represent a source of cyto-
kine and growth factors that can prime and maintain the
activation of resident cells [8]. Diamond et al demon-
strated an increase in the amount of cortical transforming
growth factor-b (TGF-b) mRNA and protein that paral-
leled the elevations in interstitial macrophage number
after unilateral obstruction [6]. The expression of this
profibrotic cytokine was mainly localized within the in-
terstitial infiltrate. This observation strongly supports the
relevance of monocytes in the development of interstitial
fibrosis. Moreover, Harris, Schreiner, and Klahr have
clearly shown that these infiltrating immune cells con-
tribute to the acute decline in renal function after the
onset of experimental hydronephrosis [11].
The chemotactic signals recruiting the monocytes into
the renal interstitium of the obstructed kidney are still
not well characterized. We observed a striking increase
of MCP-1 gene expression and urine excretion in con-
genital UPJO patients. The renal expression of this che-
mokine was directly correlated to the extent of monocyteFig. 8. EGF and MCP-1 urine excretion in congenital UPJO patients
before and after surgery. MCP-1 and EGF urine concentrations were infiltration, suggesting its potential role in the recruit-
measured before and between two and four months after surgery, as ment of these immune cells into the interstitial space.described in the Methods section and were normalized to urine creati-
This observation confirms the report by Diamond et alnine excretion. Data are represented as mean 6 SEM. *P , 0.01 vs.
control; **P , 0.01 vs. presurgery. in a rat model of unilateral ureteral obstruction, who
described an increase in MCP-1 expression within the
cortical tubules as early as 12 hours after the UUO that
was in temporal correspondence with the surge of inter-
The present study demonstrates a decreased EGF re- stitial monocyte number [6]. However, in their study,
nal expression and urine excretion in children affected MCP-1 expression was localized only by immunohisto-
by congenital UPJO, confirming previous observations chemistry on the luminal surface of tubular cells. These
in experimental models [19]. The potential pathogenic findings may raise some doubts about the tubular pro-
role for EGF in renal damage secondary to UPJO is duction of the chemokine. The data collected in the
suggested by the observation of a significant correlation present study, using the in situ hybridization, exclude
between its gene expression and the degree of tubular the possibility of a nonspecific uptake of MCP-1 protein
damage. Moreover, our data suggest a role for EGF by tubular cells, confirming its local synthesis.
in tubular cell regeneration after surgical correction of For both EGF and MCP-1, at least two variables could
UPJO. Indeed, basal EGF urine excretion strictly and influence their expression and urine excretion in UPJO
patients: obstruction and recurrent urinary tract infec-directly correlated with the improvement in MAG3
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